推荐产品
product name
LiChrosorb® RP-8 (5 µm) Hibar® RT 125-4, suitable for HPLC
物料
stainless steel column
质量水平
Agency
suitable for USP L7
产品线
LiChrosorb®
特点
endcapped: no
参数
400 bar pressure
60 °C max. temp.
技术
HPLC: suitable
mass spectrometry (MS): suitable (Low)
色谱柱长度 × 内径
12.5 cm × 4 mm
基质
fully porous particle
基质活性基团
C8 bonding phase
粒径
5 μm
孔径
100 Å pore size
operating pH range
2-7.5
分离技术
reversed phase
supercritical fluid (SFC)
储存温度
no temp limit
相关类别
一般描述
HPLC色谱柱
LiChrosorb® RP-8 是一个可靠的形状不规则的硅胶载体，具有反相特性。它非常适合分离中性、酸性和弱碱性化合物。该吸附剂装在Hibar 125-4 HPLC色谱柱中。在安装LiChroCART 4-4保护柱时，必须使用保护柱支架1.51487。
应用
- Determination of amphotericin B, liposomal amphotericin B, and amphotericin B colloidal dispersion in plasma by high-performance liquid chromatography.: This study by Egger et al. focuses on the HPLC determination of various forms of amphotericin B in plasma, utilizing LiChrosorb® RP-8 as the stationary phase. This method ensures accurate monitoring of these antifungal agents in clinical settings (Egger et al., 2001).
- Determination of peptide hydrophobicity parameters by reversed-phase high-performance liquid chromatography.: This research by Rothemund et al. used LiChrosorb® RP-8 to determine the hydrophobicity of various peptides, providing valuable insights for peptide characterization in biochemical research (Rothemund et al., 1994).
- HPLC determination of doxorubicin, doxorubicinol and four aglycone metabolites in plasma of AIDS patients.: Beijnen et al. employed LiChrosorb® RP-8 in an HPLC method to quantify doxorubicin and its metabolites in plasma, offering a robust tool for therapeutic drug monitoring in AIDS patients (Beijnen et al., 1991).
分析说明
压力： ≤ 50 bar
理论塔板数（N/m）（甲苯）： ≥ 55000
对称性（甲苯）：0.8-1.4
容量系数（甲苯）：0.5 - 1.5
理论塔板数（N/m）（甲苯）： ≥ 55000
对称性（甲苯）：0.8-1.4
容量系数（甲苯）：0.5 - 1.5
法律信息
Hibar is a registered trademark of Merck KGaA, Darmstadt, Germany
LiChrosorb is a registered trademark of Merck KGaA, Darmstadt, Germany
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门